In addition, Katarina M [96] studied the in vitro effects of IL-12 combined with interleukin-2 (IL-2), which has been used for decades in the treatment of melanoma, on the function and receptor expression of NK cells and their subsets. This evidence concerns the gene IL2 and melanoma.